+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

North America Cannabis Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product Type; Application; Compound, and Country

  • ID: 5180802
  • Report
  • August 2020
  • Region: North America
  • 142 pages
  • The Insight Partners
UP TO OFF
until Sep 30th 2021

FEATURED COMPANIES

  • Aphria, Inc.
  • Aurora Cannabis
  • Cannabis Science, Inc.
  • Canopy Growth Corporation
  • Medical Marijuana, Inc.
  • Terra Tech Corp.
The North America cannabis market is expected to reach US$ 65,161.4 million by 2027 from US$ 6,036.9 million in 2019. The market is anticipated to grow at a CAGR of 29.9% from 2020 to 2027.

The growth of the North America cannabis market is attributed to increasing approvals for cannabis-based products and growing sales and inventory for cannabis. However, stringent regulatory framework for cannabis is likely to hinder the market growth during the forecast period.

Canada is among the fastest and largest countries in terms of production of cannabis and commercialization of its products. In October 2018, the Federal Government accepted the Cannabis Act, and since after the cannabis industry has boomed in the country. Various companies have initiated production and manufacturing to embrace the recreational and medical use of cannabis. According to the Government of Canada's data published in May 2020, ~7,840,577 packaged units of cannabis were sold in Canada. It was sold for medical and recreational uses. Approximately 73% of total sales were contributed by dried cannabis, whereas cannabis extracts contributed 14%, and edible cannabis contributed 13% in the country's total sales of cannabis.

In addition, the data also stated that ~43,309,909 packaged units of cannabis products are kept in inventory by cultivators, manufacturers, and suppliers across the country. Among the total inventories, 42% is held by the distributors and retailers for packaged units of cannabis-based products. Moreover, the number of cultivators is growing rapidly across the country. For instance, as of May 2020, ~6,518,054 cultivators had a federal license. Thus, growing cultivation has enabled to increase sales and inventory for packed and unpacked cannabis products in the market. Hence, it is expected to grow the cannabis market significantly during the forecast period.

Based on product type, the North America cannabis market is segmented into flower, concentrates, and others. In 2019, the flowers segment held a largest market share of the cannabis market. However, the concentrates segment is expected to witness the highest CAGR over the forecast period.

In terms of application, the North America cannabis market is segmented into medical and recreational. In 2019, the medical segment held a larger share of the market. However, the recreational segment is anticipated to witness a faster growth in the cannabis market.

Based on compound, the North America cannabis market is segmented into tetrahydrocannabinol (THC)-dominant, cannabidiol (CBD)-dominant, and balanced THC and CBD. In 2019, the tetrahydrocannabinol (THC)-dominant segment held the largest share of the market. However, the cannabidiol (CBD)-dominant segment is anticipated to witness the fastest growth in the cannabis market.

Food and Drug Administration, Multidisciplinary Association for Psychedelic Studies and Mexico's Federal Commission for the Protection against Sanitary Risk, and Drug Enforcement Administration are among the major primary and secondary sources for the North America cannabis market.

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America cannabis market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the North America cannabis market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aphria, Inc.
  • Aurora Cannabis
  • Cannabis Science, Inc.
  • Canopy Growth Corporation
  • Medical Marijuana, Inc.
  • Terra Tech Corp.
1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 North American Cannabis Market- By Product Type
1.3.2 North American Cannabis Market- By Application
1.3.3 North American Cannabis Market - By Compound
1.3.4 North American Cannabis Market- By Region

2. Cannabis Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Cannabis - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.3 Expert Opinion

5. North America Cannabis Market - Industry Dynamics
5.1 Key Drivers
5.1.1 Growing Approvals for Cannabis-based Products
5.1.2 Growing Sales and Inventory for Cannabis
5.2 Key Market Restraints
5.2.1 Stringent Regulatory Framework for Cannabis
5.3 Key Market Opportunities
5.3.1 Rising Market Consolidations
5.4 Future Trends
5.4.1 Growing Acceptance of Cannabis Products
5.5 Impact Analysis

6. Cannabis Market - Regional Analysis
6.1 North America Cannabis Market Revenue Forecast And Analysis
6.2 Market Positioning of Key Players

7. Cannabis Market Analysis - By Product Type
7.1 Overview
7.2 Cannabis Market Revenue Share, by Product Type, 2019 and 2027 (%)
7.2.1 North America Cannabis Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
7.3 Flowers Market
7.3.1 Overview
7.3.2 Flowers Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Concentrates Market
7.4.1 Overview
7.4.2 Concentrates Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Others Market
7.5.1 Overview
7.5.2 Others Market Revenue and Forecast to 2027 (US$ Mn)

8. Cannabis Market - By Application
8.1 Overview
8.2 Cannabis Market, by Application, 2019 and 2027 (%)
8.2.1 North America Cannabis Market, by Application - Revenue and Forecast to 2027 (USD Million)
8.3 Medical Market
8.3.1 Overview
8.3.2 Medical Market Revenue and Forecast to 2027 (US$ Mn)
8.3.3 Pain Management
8.3.3.1 Overview
8.3.3.2 Pain Management Market Revenue and Forecast to 2027 (US$ Mn)
8.3.4 Neurological Health Management
8.3.4.1 Overview
8.3.4.2 Neurological Health Management Market Revenue and Forecast to 2027 (US$ Mn)
8.3.5 Mental Health Management
8.3.5.1 Overview
8.3.5.2 Mental Health Management Market Revenue and Forecast to 2027 (US$ Mn)
8.3.6 Others
8.3.6.1 Overview
8.3.6.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Recreational Market
8.4.1 Overview
8.4.2 Recreational Market Revenue and Forecast to 2027 (US$ Mn)

9. Cannabis Market - By Compound
9.1 Overview
9.2 Cannabis Market, by Compound, 2019 and 2027 (%)
9.2.1 North America Cannabis Market, by Compound - Revenue and Forecast to 2027 (USD Million)
9.3 Tetrahydrocannabinol (THC)-Dominant Market
9.3.1 Overview
9.3.2 Tetrahydrocannabinol (THC)-Dominant Market Revenue and Forecast to 2027 (US$ Mn)
9.4 Cannabidiol (CBD)-Dominant Market
9.4.1 Overview
9.4.2 Cannabidiol (CBD)-Dominant Market Revenue and Forecast to 2027 (US$ Mn)
9.5 Balanced THC and CBD Market
9.5.1 Overview
9.5.2 Balanced THC and CBD Market Revenue and Forecast to 2027 (US$ Mn)

10. Cannabis Market- Regional Analysis
10.1 North America: Cannabis Market
10.2 Overview
10.3 North America Cannabis Market Revenue and Forecasts to 2027 (US$ Mn)
10.4 North America Cannabis Market Revenue and Forecasts, by Product Type(US$ Mn)
10.5 North America Cannabis Market Revenue and Forecasts, By Application (US$ Mn)
10.5.1.1 North America Medical Market Revenue and Forecasts, By Type (US$ Mn)
10.6 North America Cannabis Market Revenue and Forecasts, by Compound (US$ Mn)
10.7 North America Cannabis Market Revenue and Forecasts to 2027, By Country (%)
10.8 US Cannabis Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.1 US Cannabis Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.2 US Cannabis Market Revenue and Forecasts, by Product Type(US$ Mn)
10.8.3 US Cannabis Market Revenue and Forecasts, by Application (US$ Mn)
10.8.3.1 US Medical Market Revenue and Forecasts, By Type (US$ Mn)
10.8.3.2 US Cannabis Market Revenue and Forecasts, by Compound (US$ Mn)
10.9 Canada Cannabis Market Revenue and Forecasts to 2027 (US$ Mn)
10.9.1 Canada Cannabis Market Revenue and Forecasts to 2027 (US$ Mn)
10.9.2 Canada Cannabis Market Revenue and Forecasts, by Product Type(US$ Mn)
10.9.3 Canada Cannabis Market Revenue and Forecasts, by Application (US$ Mn)
10.9.3.1 Canada Medical Market Revenue and Forecasts, By Type (US$ Mn)
10.9.4 Canada Cannabis Market Revenue and Forecasts, by Compound (US$ Mn)
10.10 Mexico Cannabis Market Revenue and Forecasts to 2027 (US$ Mn)
10.10.1 Mexico Cannabis Market Revenue and Forecasts to 2027 (US$ Mn)
10.10.2 Mexico Cannabis Market Revenue and Forecasts, by Product Type(US$ Mn)
10.10.3 Mexico Cannabis Market Revenue and Forecasts, by Application (US$ Mn)
10.10.3.1 Mexico Medical Market Revenue and Forecasts, By Type (US$ Mn)
10.10.4 Mexico Cannabis Market Revenue and Forecasts, by Compound (US$ Mn)

11. Impact of COVID-19 Pandemic on North America Cannabis Market
11.1 North America: Impact Assessment of COVID-19 Pandemic

12. Cannabis Market-Key Company Profiles
12.1 Aphria, Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product Portfolio
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Aurora Cannabis
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Financial Overview
12.2.4 Product Portfolio
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Cannabis Science, INC.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Financial Overview
12.3.4 Product Portfolio
12.3.5 Swot Analysis
12.3.6 Key Developments
12.4 Canopy Growth Corporation
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Overview
12.4.4 Product Portfolio
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Medical Marijuana, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Financial Overview
12.5.4 Product portfolio
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 VIVO Cannabis Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Financial Overview
12.6.4 Product Portfolio
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Tikun Olam
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Terra Tech Corp.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Financial Overview
12.8.4 Product Portfolio
12.8.5 Swot Analysis
12.8.6 Key Developments
12.9 Tilray
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Overview
12.9.4 Product Portfolio
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 The Cronos Group
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Financial Overview
12.10.4 Product portfolio
12.10.5 SWOT Analysis
12.10.6 Key Developments

13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms
Note: Product cover images may vary from those shown
  • Aphria, Inc.
  • Aurora Cannabis
  • Cannabis Science, Inc.
  • Canopy Growth Corporation
  • Medical Marijuana, Inc.
  • VIVO Cannabis Inc.
  • Tikun Olam
  • Terra Tech Corp.
  • Tilray
  • The Cronos Group
Note: Product cover images may vary from those shown
Adroll
adroll